Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.
about
Preoperative chemotherapy for resectable thoracic esophageal cancerUnderstanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalPreoperative therapy in locally advanced esophageal cancerReevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 YearsIs there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.Imaging strategies in the management of oesophageal cancer: what's the role of MRI?Perioperative therapy for esophageal cancer.Multimodality management of esophageal cancer.Pathological characteristics of esophageal cancer.Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.Immunotherapy for gastrointestinal malignancies.Potential of Baseline Computed Tomography to Predict Long-Term Survival of Patients With Locally Advanced Esophageal Cancer Treated With Preoperative Chemotherapy: A Retrospective Cohort Study.The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC).Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.Oesophageal cancer--an overview.Curative treatment of esophageal cancer; an evidenced based review.Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.Neoadjuvant therapy for esophageal cancerCetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer.Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study.Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis.Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinomaNeoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism.Survival after recurrent esophageal carcinoma has not improved over the past 18 years.Outcome, complications, and mortality of an intrathoracic anastomosis in esophageal cancer in patients without a preoperative selection with a risk score.Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.Early Enteral Nutrition is Associated with Faster Post-Esophagectomy Recovery in Chinese Esophageal Cancer Patients: A Retrospective Cohort Study.The frontline of esophageal cancer treatment: questions to be asked and answered.Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
P2860
Q24187910-101DB58A-C710-41DB-8856-856F75A7BEB8Q26798220-1C97793C-7456-4A45-B080-8F50A2842F8EQ28070310-642BD194-D390-451E-B4C2-167B2CFEBE80Q28081365-9AFE6B9B-1C92-4A9F-888E-756887CC1F05Q34361948-F4469A63-8D0A-489D-B1A7-99158D52412BQ34583617-C9C6CBBF-83F5-442E-82F7-8D33D68E9224Q34663544-775C37AA-977B-4CBC-9CAC-610D31C27F80Q34981111-EAD2920A-FEC0-43B7-B5CC-504E6A50BE7EQ35205129-516D8EE4-96E6-4F37-934D-25B30EF421B8Q36149779-487B80B8-8C91-4F61-B1E2-078AC2F32D22Q36602174-8E255303-5106-4016-9B42-E672FCADA766Q36891944-741D8EB8-BD63-4006-844F-C8266B340F70Q37427959-84F20799-FAC3-41F2-80D1-6669A61CBD31Q37612343-60B0DA7A-04B6-4279-8DBC-B4707FC30110Q38072285-8FE361BB-F967-468D-8F04-160C5E43E952Q38119170-6AFEFC88-BDC5-467F-9A2B-DC9026B12717Q38184934-EB131BFF-FADF-44E6-9998-D4B99FC420D8Q38260692-19916157-1039-4ABB-B2F4-02B27A4FBA0FQ38385570-27C9BBAD-4956-4D43-96AC-E282FEF1C5CCQ38631363-40DC0426-269F-456C-9832-8A7D825E35D3Q38636439-5A49A451-1AAB-4CAC-AF7E-46D651B30D40Q38738233-1B06B3A1-379D-4433-9587-C3B4188FD2D4Q38831243-132E61BC-BA63-4061-BC1C-FF31A9BC8A4AQ39053426-6EFE5968-6250-4A2B-8EE1-0DE08863C994Q39167405-6F861AE5-A23F-430F-B1C9-5FFDAD6C36E1Q39200297-99027158-822C-4C40-8CBC-CA51DCCD751BQ39714617-941979DC-784A-49FC-99C2-3D84D1ED2FC5Q40814495-6EFB398F-284B-4944-A36D-8C8B8024C460Q41055901-EE41B495-1CFE-4DF8-A436-418D902B117BQ41613887-68CA785E-912E-4F1D-A9F4-3A00AB1C6B41Q41729508-4972ED56-0B32-421D-92F7-CA7311E57A97Q45770766-3F23D12F-D47F-4962-89F5-8EECBE553186Q45806598-A4A4987F-2569-4372-A0D2-5333DB5EEFEBQ49726258-97D12448-5070-4944-B945-2ABB9C84D451Q50126165-CB5B1C9F-F5B4-4F51-9E1D-0FF9E9AD78FDQ52581745-F9CF2CC5-5FB8-479E-8FF3-8C1D883A6562Q53061712-D2603B57-6E4D-40CC-86AA-6F7DD12063D6Q56896166-B68D36F9-A1C2-4EB9-971E-BAD219AF05C7
P2860
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemotherapy followed by surge ...... a randomized controlled trial.
@ast
Chemotherapy followed by surge ...... a randomized controlled trial.
@en
type
label
Chemotherapy followed by surge ...... a randomized controlled trial.
@ast
Chemotherapy followed by surge ...... a randomized controlled trial.
@en
prefLabel
Chemotherapy followed by surge ...... a randomized controlled trial.
@ast
Chemotherapy followed by surge ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Chemotherapy followed by surge ...... a randomized controlled trial.
@en
P2093
Ate van der Gaast
Bas Pl Wijnhoven
Fiebo Jw Ten Kate
Hugo W Tilanus
Jan Jb van Lanschot
Jurjen J Boonstra
Mark I van Berge Henegouwen
Mark van Heijl
Peter D Siersema
Tjebbe C Kok
P2860
P2888
P356
10.1186/1471-2407-11-181
P407
P577
2011-05-19T00:00:00Z
P5875
P6179
1035591572